Philips Healthcare has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its IQon spectral CT scanner.
First showcased at the 2013 RSNA meeting, IQon analyzes signals from two x-ray energies to determine changes in tissue composition. Clinicians can view the conventional grayscale anatomical images along with the spectral information from the same scan, according to the vendor.
Philips will be showing IQon at the upcoming 2014 RSNA meeting in Chicago. The scanner is now currently available for order in 36 countries, the company said.
